Browse by Section 100 Item List

Highly Specialised Drugs Program (Public Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in public hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies and some of these prescriptions can be dispensed by a community pharmacy. A patient may be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the PBS. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 10136L MACITENTANmacitentan 10 mg tablet, 30 1 30 5
MP 12147H MACITENTANmacitentan 10 mg tablet, 30 1 30 5
MP 2015C MANNITOLmannitol 40 mg powder for inhalation, 280 capsules 4 4 5
MP 12007Y MEPOLIZUMABmepolizumab 100 mg/mL injection, 1 mL pen device 1 1 7
MP 12021Q MEPOLIZUMABmepolizumab 100 mg/mL injection, 1 mL pen device 1 1 0
MP 12064Y MEPOLIZUMABmepolizumab 100 mg/mL injection, 1 mL pen device 1 1 5
MP 13237Q MEPOLIZUMABmepolizumab 100 mg/mL injection, 1 mL pen device 1 1 5
MP 12154Q METHOXSALENmethoxsalen 200 microgram/10 mL injection, 12 x 10 mL vials 0.08 1 5
MP 12156T METHOXSALENmethoxsalen 200 microgram/10 mL injection, 12 x 10 mL vials 0.17 2 6
MP 12854M METHOXSALENmethoxsalen 200 microgram/10 mL injection, 12 x 10 mL vials 0.17 2 0
MP 12876Q METHOXSALENmethoxsalen 200 microgram/10 mL injection, 12 x 10 mL vials 1 12 1
MP 5794Y METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 30 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5795B METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 50 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5796C METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 75 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5797D METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 100 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5798E METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 120 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5799F METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 200 microgram/0.3 mL injection, 0.3 mL syringe 2 2 5
MP 5800G METHOXY POLYETHYLENE GLYCOL-EPOETIN BETAmethoxy polyethylene glycol-epoetin beta 360 microgram/0.6 mL injection, 0.6 mL syringe 2 2 5
MP 11553C MIDOSTAURINmidostaurin 25 mg capsule, 56 1 56 2
MP 11505M MIDOSTAURINmidostaurin 25 mg capsule, 112 1 112 2
MP 11552B MIDOSTAURINmidostaurin 25 mg capsule, 112 1 112 2
MP 1839T MYCOPHENOLATEmycophenolate mofetil 250 mg capsule, 50 12 600 5
MP 9503E MYCOPHENOLATEmycophenolate 180 mg enteric tablet, 120 2 240 5
MP 9504F MYCOPHENOLATEmycophenolate 360 mg enteric tablet, 120 2 240 5
MP 9501C MYCOPHENOLATEmycophenolate mofetil 250 mg capsule, 100 6 600 5
MP 9500B MYCOPHENOLATEmycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL 2 2 5
MP 9502D MYCOPHENOLATEmycophenolate mofetil 500 mg tablet, 50 6 300 5